Moberg Pharma Signs Distribution Agreement in Middle East and North Africa

25-10-2013 Business Wire HealthComments (0)

Pharmaceutical

Regulatory News: Moberg Pharma AB (STO:MOB) today signed an exclusive agreement with Leosons International to distribute Moberg’s Kerasal Nail™ in MENA (Middle East and North Africa). Leosons has been successfully distributing Moberg’s JointFlex® brand in the Middle East for almost 10 years.  Leosons intends to launch Kerasal Nail™ in 2014. The agreement encompasses sixteen markets, including Egypt, Iraq, Saudi Arabia, Tunisia and UAE. About Kerasal Nail™ and nail di

Read more on Business Wire Health

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top